1.30CNY
67.80 MCNY
681.68 MCNY
About ENWEI PHARMACEUTIC
Sector
CEO
Yong Jiang Xue
Headquarters
Changdu
Website
Employees (FY)
1.61 K
Founded
2005
ISIN
CNE100005LC7
FIGI
BBG00XT3FRT2
Enwei Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of proprietary Chinese and chemical medicines. It focuses on gynecological products, pediatric medicines, and respiratory medicines. The company was founded on May 19, 2005 and is headquartered in Changdu, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 301331 is 40.20 CNY — it has increased by 5.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange ENWEI PHARMACEUTIC stocks are traded under the ticker 301331.
301331 stock is 7.47% volatile and has beta coefficient of 1.36. Check out the list of the most volatile stocks — is ENWEI PHARMACEUTIC there?
Yes, you can track ENWEI PHARMACEUTIC financials in yearly and quarterly reports right on TradingView.
301331 stock has risen by 6.38% compared to the previous week, the month change is a 9.33% rise, over the last year ENWEI PHARMACEUTIC has showed a 7.14% increase.
301331 net income for the last quarter is 8.97 M CNY, while the quarter before that showed 36.29 M CNY of net income which accounts for −75.28% change. Track more ENWEI PHARMACEUTIC financial stats to get the full picture.
Yes, 301331 dividends are paid annually. The last dividend per share was 1.60 CNY. As of today, Dividend Yield (TTM)% is 4.21%. Tracking ENWEI PHARMACEUTIC dividends might help you take more informed decisions.
Like other stocks, 301331 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENWEI PHARMACEUTIC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 1.61 K employees. See our rating of the largest employees — is ENWEI PHARMACEUTIC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENWEI PHARMACEUTIC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENWEI PHARMACEUTIC stock shows the buy signal. See more of ENWEI PHARMACEUTIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.